Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): A California Cancer Registry analysis

被引:52
|
作者
Lara, Matthew S. [1 ]
Brunson, Ann [2 ,3 ]
Wun, Ted [2 ,3 ]
Tomlinson, Ben [2 ,3 ]
Qi, Lihong [2 ,3 ,4 ]
Cress, Rosemary [2 ,3 ,4 ]
Gandara, David R. [2 ,3 ]
Kelly, Karen [2 ,3 ]
机构
[1] Davis Senior High Sch, Davis, CA USA
[2] Univ Calif Davis, Sch Med, Div Hematol Oncol, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Ctr Comprehens Canc, Sch Med, Sacramento, CA 95817 USA
[4] UC Davis Sch Med, DC Davis Dept Publ Hlth Sci, Davis, CA USA
关键词
Non-small cell lung cancer; Young patients; Cause specific survival; Registry analysis; Epidemiology; Prognosis; EPIDEMIOLOGY; SURVEILLANCE; TRENDS; OLD;
D O I
10.1016/j.lungcan.2014.04.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Non-small cell lung cancer (NSCLC) is uncommonly diagnosed in patients younger than 50 years of age. We analyzed the California Cancer Registry (CCR) to describe epidemiologic characteristics and outcomes in this patient subset and to identify factors prognostic for cause-specific survival (CSS). Methods: Patients diagnosed with NSCLC between 1/1/98 through 12/31/09 and reported to the (CCR) as of October 2011 were included. The primary outcome measure was CSS. Cox regression models were used to evaluate predictors of CSS in young patients with NSCLC, adjusted for potential confounders. Interaction analysis was performed between age groups (<50 vs. >= 50) and specific demographic and tumor covariates. Results: We identified 132,671 lung cancer cases, of which 114,451 (86.3%) had NSCLC. Of these, 6389 (5.6%) were <50 years of age (median, 46 years). The most common histology was adenocarcinoma (3697, 57.9%). Most patients had stage III (1522, 23.8%) or IV (3655, 57.2%) disease. Fewer young patients were diagnosed in recent years (n, % of total NSCLC population of that era): 1998-2001 (2355, 6.0), 2002-2005 (2182, 5.7), and 2006-2009 (1852, 5.0), P<0.001. Multivariate analysis showed that age <50 years was an independent predictor of improved CSS (HR 0.827, P<0.001). Significant predictors of better CSS in patients <50 years included female sex, Asian or Hispanic ethnicity, lower stage, later year of diagnosis, and higher socioeconomic status, among others. Adenocarcinoma histology was not associated with improved CSS in this patient subset (HR 0.987, P=0.78). Interaction analysis revealed that Hispanic race and bronchioloalveolar histology had differential CSS outcomes dependent on age group. Conclusions: This large registry study found that age <50 years is an independent predictor of improved CSS. Variables prognostic for CSS differed somewhat from those in older patients. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 50 条
  • [1] Predictors of Survival in Small Cell Lung Cancer (SCLC) Patients (pts) &lt; 50 Years of Age: Results from the California Cancer Registry (CCR)
    Lara, Joshua D.
    Brunson, Ann
    Riess, Jonathan W.
    Kelly, Karen
    Lara, Primo, Jr.
    Gandara, David R.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S501 - S501
  • [2] Multicenter Analysis of Lung Cancer Patients Younger Than 45 Years in Shanghai
    Zhang, Jie
    Chen, Su-feng
    Zhen, Ying
    Xiang, Jiaqing
    Wu, Chunxiao
    Bao, Pingping
    Luketich, James
    Hu, Hong
    Zhou, Xian
    Zhang, Junhua
    Yao, Shihua
    Chen, Hai-Quan
    CANCER, 2010, 116 (15) : 3656 - 3662
  • [3] Lung Cancer in Individuals Less Than 50 Years of Age
    Guntulu Ak
    Muzaffer Metintas
    Selma Metintas
    Huseyin Yildirim
    Sinan Erginel
    Fusun Alatas
    Lung, 2007, 185 : 279 - 286
  • [4] Lung cancer in individuals less than 50 years of age
    Ak, Guntulu
    Metintas, Muzaffer
    Metintas, Selma
    Yildirim, Huseyin
    Erginel, Sinan
    Alatas, Fusun
    LUNG, 2007, 185 (05) : 279 - 286
  • [5] Characterization of pneumonia and other factors leading to poorer survival across all age groups in patients with non-small cell lung cancer (NSCLC)
    Weinberg, Frank D.
    Zhao, Lili
    Chellappa, Niranjana
    Kalemkerian, Gregory P.
    Ramnath, Nithya
    JOURNAL OF THORACIC DISEASE, 2021, 13 (02) : 986 - +
  • [6] Age at diagnosis is a heterogeneous factor for non-small cell lung cancer patients
    Chen, Tao
    Zhou, Fangyu
    Jiang, Weili
    Mao, Rui
    Zheng, Hui
    Qin, Linlin
    Chen, Chang
    JOURNAL OF THORACIC DISEASE, 2019, 11 (06) : 2251 - 2266
  • [7] SURVIVAL OUTCOME IN STAGE IIIB NON-SMALL CELL LUNG CANCER PATIENTS YOUNGER THAN 45 YEARS: RETROSPECTIVE ANALYSIS OF 145 PATIENTS.
    Topkan, Erkan
    Parlak, Cem
    Guler, Ozan C.
    Selek, Ugur
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1149 - S1149
  • [8] Non-small cell lung cancer in adults under 40 years of age
    Lemaire, M.
    Durieux, V.
    Meert, A. -p.
    Berghmans, T.
    REVUE DES MALADIES RESPIRATOIRES, 2024, 41 (10) : 727 - 737
  • [9] Lung cancer in patients younger than 40 years of age
    Maruyama, R
    Yoshino, I
    Yohena, T
    Uehara, T
    Kanematsu, T
    Kitajima, M
    Teruya, T
    Ichinose, Y
    JOURNAL OF SURGICAL ONCOLOGY, 2001, 77 (03) : 208 - 212
  • [10] Survival analysis of young adults from a Brazilian cohort of non-small cell lung cancer patients
    Nicolau, Jessica Silva
    Mendoza Lopez, Rossana Veronica
    de Moraes Luizaga, Carolina Terra
    Ribeiro, Karina Braga
    Roela, Rosimeire Aparecida
    Maistro, Simone
    Hirata Katayama, Maria Lucia
    Mendonca Natalino, Renato Jose
    de Castro Jr, Gilberto
    Neto, Jose Eluf
    Azevedo Koike Folgueira, Maria Aparecida
    ECANCERMEDICALSCIENCE, 2021, 15